“There can be no keener revelation of a society’s soul than the way it treats its children.”
I believe in using the highly innovative, emerging science that is available to us, to help children with severe illness. Such children cannot always advocate for themselves. Every child is important, and their perspectives, opinions and potential, need to be encouraged. My career has been dedicated to Clinical Development, Translational Science and Medical Leadership in an effort to transform the lives of children and their families.
Business Purpose
Suyash Prasad Consulting, LLC brings dynamic, creative and thoughtful leadership to the fields of gene therapy, genetic medicines, orphan disease and pediatrics. I provide expert consultation and guidance on all aspects of drug development, and specialize in advising organizations that are focused on the development of highly-scientific and innovative medications to treat children with severe disease. I partner with organizations in the clinical, scientific, investment and advocacy environments to achieve these aims and meaningful, lasting outcomes.
Dedicated Focus Areas
Gene Therapy and Genetic Medicines
Next generation medicine targeting underlying causes of genetic diseases.
Orphan and Rare Diseases
Treatments for conditions affecting fewer than 200,000 people in the US, and fewer than 1 in 2,000 in the EU.
Pediatric Medicines Development
Efficacy and safety research to produce medications for children across the age spectrum.
Expertise
Biotechnology Executive Leadership, Financing and Investor Relationships
Clinical Trial Design, Strategy and Execution
Leading Regulatory Agency Strategy and Communications
Patient Advocacy and Engagement
Translational Science
Business Development and Acquisitions / Partnerships
Children’s Research Ethics
Entrepreneurial Company Creation
Speaking Engagements
I am pleased to have been invited to speak on many occasions in my areas of expertise. These have included presentations at academic scientific congresses, patient advocacy meetings, governmental organizations and private enterprises. Please contact me if you would like to discuss an upcoming speaking opportunity.